1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 3:Multivariate analysis of prognostic factors using the Cox proportional hazards model with forward stepwise selection in 180 patients with HGA and spectra obtained at STEa
Variable/Value No. Hazard Ratio (95% CI) P Clinical parameters/treatment <.001 Conservative support 58 11.564 (7.242–18.465) Radiotherapy alone 31 1.768 (1.100–2.841) Chemoradiotherapy 91 1.000 Spectroscopy parameters Intensity signals normalized to unit-length (NI) NI3.67 <.001 <0.0473 71 2.132 (1.504–3.023) >0.0473 109 1.000
a Age (<50 years vs >50 years), sex, WHO grade, KPS, extent of surgery, the spectroscopic parameters normalized intensity signal at 0.98 ppm, and the ratio between intensity signals at 3.67 and 0.98 ppm were not selected as elective prognostic factors.